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ABSTRACT 
Acute inflammation in peritoneal dialysis : experimental studies in rats 
Characterization of regulatory mechanisms 
Farhan Bazargani 
Department of Anatomy and Cell Biology, The Sahlgrenska Academy at 
Göteborg University, Box 420, SE-405 30 Göteborg, Sweden 
The predominant problems associated with peritoneal dialysis (PD) are ultrafiltration 
failure and peritonitis. PD maintains a state of intraperitoneal inflammation that affects the 
structure and function of the peritoneal membrane, potentially impairing ultrafiltration 
efficiency. Paradoxically, some PD fluids also have anti-inflammatory properties that may 
compromise the immune defense against peritonitis. This anti-inflammatory feature is mostly 
due to the glucose degradation products (GDPs), formed during heat-sterilization and storage 
of PD fluids. The main purpose of the present thesis was to study regulatory mechanisms 
behind the acute intraperitoneal inflammatory response in PD in the presence and absence of 
experimental peritonitis. 
Rats were exposed to a single dose of heat- or filter sterilized PD fluids either as an 
i.p. injection or as an infusion through an indwelling catheter, with or without 
supplementations, or pretreatment of the animals. The dwell fluid was analyzed zero, two and 
four hours later concerning activation of the complement and coagulation cascades, neutrophil 
recruitment and respiratory burst, ultrafiltration volumes, cytokine-induced neutrophil 
chemoattractant (CINC-1), rat mast cell protease 2 (RMCP-2), glucose, urea and histamine 
concentrations and ex vivo/in vitro intraperitoneal chemotactic activity. 
Exposure to filter sterilized PD fluid alone induced intraperitoneal complement 
activation and coagulation, neutrophil recruitment and increased the levels of CINC-1 during 
the dwell. Intraperitoneal concentrations of the mast cell markers histamine and RMCP-2 
changed little during the dwells and did not indicate mast cell activation. Low molecular 
weight heparin (LMWH) and C5 blockade improved ultrafiltration. Pretreatment with cobra 
venom factor, known decomplementing agent, blocked the CINC-1 release and the neutrophil 
recruitment and improved ultrafiltration. In combination with experimental peritonitis, heat 
sterilized PD fluid compared to filter sterilized, inhibited the CINC-1 release and the 
recruitment of neutrophils to the peritoneal cavity without affecting the intraperitoneal 
complement activation. 
The results of the present thesis indicate that addition of LMWH to the PD fluid 
improves ultrafiltration, probably by blocking C5a activity. C5 blockade seems to improve 
ultrafiltration by a mechanism that involves a reduction in glucose transport, possibly by 
reducing C5 induced vasodilation. Complement activation is an early step in the acute 
reaction to PD and probably mediates the downstream events that lead to the recruitment of 
inflammatory cells to the peritoneal cavity. The cells involved in the release of CINC-1 later 
in this sequence are probably the mesothelial cells. During experimental peritonitis, heat 
sterilized PD fluids inhibited the neutrophil respiratory burst response of intraperitoneal 
neutrophils. Heat sterilized PD fluids also inhibit the recruitment of neutrophils to the 
peritoneal cavity by a mechanism independent of complement activation but probably 
depending on cytokine CINC-1 release during peritonitis. 
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ABSTRACT 
Acute inflammation in peritoneal dialysis : experimental studies in rats 
Characterization of regulatory mechanisms 
Farhan Bazargani 
Department of Anatomy and Cell Biology, The Sahlgrenska Academy at 
Göteborg University, Box 420, SE-405 30 Göteborg, Sweden 
The predominant problems associated with peritoneal dialysis (PD) are ultrafiltration 
failure and peritonitis. PD maintains a state of intraperitoneal inflammation that affects the 
structure and function of the peritoneal membrane, potentially impairing ultrafiltration 
efficiency. Paradoxically, some PD fluids a lso have anti-inflammatory properties that may 
compromise the immune defense against peritonitis. This anti-inflammatory feature is mostly 
due to the glucose degradation products (GDPs), formed during heat-sterilization and storage 
of PD fluids. The main purpose of the present thesis was to study regulatory mechanisms 
behind the acute intraperitoneal inflammatory response in PD in the presence and absence of 
experimental peritonitis. 
Rats were exposed to a single dose of heat- or filter sterilized PD fluids either as an 
i.p. injection or as an infusion through an indwelling catheter, with or without 
supplementations, or pretreatment of the animals. The dwell fluid was analyzed zero, two and 
four hours later concerning activation of the complement and coagulation cascades, neutrophil 
recruitment and respiratory burst, ultrafiltration volumes, cytokine-induced neutrophil 
chemoattractant (CINC-1), rat mast cell protease 2 (RMCP-2), glucose, urea and histamine 
concentrations and ex vivo/in vitro intraperitoneal chemotactic activity. 
Exposure to filter sterilized PD fluid alone induced intraperitoneal complement 
activation and coagulation, neutrophil recruitment and increased the levels of CINC-1 during 
the dwell. Intraperitoneal concentrations of the mast cell markers histamine and RMCP-2 
changed little during the dwells and did not indicate mast cell activation. Low molecular 
weight heparin (LMWH) and C5 blockade improved ultrafiltration. Pretreatment with cobra 
venom factor, known decomplementing agent, blocked the CINC-1 release and the neutrophil 
recruitment and improved ultrafiltration. In combination with experimental peritonitis, heat 
sterilized PD fluid compared to filter sterilized, inhibited the CINC-1 release and the 
recruitment of neutrophils to the peritoneal cavity without affecting the intraperitoneal 
complement activation. 
The results of the present thesis indicate that addition of LMWH to the PD fluid 
improves ultrafiltration, probably by blocking C5a activity. C5 blockade seems to improve 
ultrafiltration by a mechanism that involves a reduction in glucose transport, possibly by 
reducing C5 induced vasodilatation. Complement activation is an early step in the acute 
reaction to PD and probably mediates the downstream events that lead to the recruitment of 
inflammatory cells to the peritoneal cavity. The cells involved in the release of CINC-1 later 
in this sequence are probably the mcsothelia! cells. During experimental peritonitis, heat 
sterilized PD fluids inhibited the neutrophil respiratory burst response of intraperitoneal 
neutrophils. Heat sterilized PD fluids also inhibit the recruitment of neutrophils to the 
peritoneal cavity by a mechanism independent of complement activation but probably 
depending on cytokine CINC-1 release during peritonitis. 
Key words: Peritoneal Dialysis, Rat, Ultrafiltration, Heparin, Complement, Coagulation, CINC-1, 
Neutrophil recruitment. Mast cells 
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TNF-a tumor necrosis factor alpha 
TXB, thromboxane B2 
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INTRODUCTION 
Peritoneal dialysis 
Continuous ambulatory peritoneal dialysis (CAPD) is a treatment for uremic patients 
with end-stage renal failure. In this treatment, the peritoneal cavity is repeatedly 
filled with a hypertonic peritoneal dialysis (PD) fluid through a permanent catheter 
implanted in the abdominal wall, and then drained, usually after 4-6 hours of dwell 
time. During CAPD, the peritoneal membrane is used as an endogenous dialyzing 
membrane to remove metabolic waste products (primarily urea and creatinine) and 
water from the blood circulation to the peritoneal cavity by a combination of 
diffusion and osmosis [1, 2], 
Peritoneal dialysis was first introduced in patients with acute renal disease. With the 
development of more sophisticated methods for infusion of PD fluids, the treatment 
could also be used on patients with chronic renal disease. Since CAPD was first used 
almost 25 years ago, it has become an alternative to haemodialysis for treatment of 
patients with end-stage renal failure. However, the predominant problems with 
CAPD remain. These are a high incidence of peritonitis, and ultrafiltration failure [3]. 
Peritonitis remains a major complication of PD, accounting for much of the morbidity 
associated with the technique. The most common organisms producing peritonitis 
are Gram-positive and include mainly Staphylococcus epidermidis and Staph, aureus [4]. 
With declining rates of Gram-positive infection secondary to changes in catheter 
connection technique, the proportion of infections secondary to Gram-negative 
organisms is increasing. In most cases, Gram-negative peritonitis is caused by 
intestinal flora. This can result from abdominal perforation, instrumentation, or other 
abdominal processes. However, in many cases, an etiology of the infection is not 
found [5]. Peritonitis accounts for 15-35% of hospital admissions and is the major 
cause of transfer to haemodialysis [6], 
Ultrafiltration occurs in PD when there is net fluid filtration into the peritoneum. For 
osmotically driven ultrafiltration to occur, a semi-permeable membrane must 
separate two physiological compartments, with one of th e compartments having an 
effective osmolality to induce fluid shift. The increased osmolality of hypertonic 
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glucose-containing PD solutions produces an osmotic gradient, which favors fluid 
movement from the vascular compartment to the peritoneal cavity [7], The capillary 
membrane has the physiological characteristics of a semi-permeable membrane. The 
microcirculation at the peritoneal surface is exposed to the hyperosmotic effects of 
PD solutions via the mesothelial lining and the submesothelial connective tissue. 
Numerous endogenous and exogenous vasoactive agents have been shown to 
modify blood flow in the peritoneal microcirculation. A wide variety of drugs, 
hormones, neurotransmitters, and mediators of inflammation alter mesenteric 
vascular resistance. In general, vasodilators in the splanchnic circulation enhance 
peritoneal clearance and increase capillary filtration coefficients, while 
vasoconstrictors decrease peritoneal clearance and reduce capillary filtration 
coefficients [8], Diffusion of small molecules (e.g., urea and glucose) is dependent on 
the capillary blood flow during PD [9]. An increase in capillary flow would increase 
the out-diffusion of sub stances such as glucose, which is the most common osmotic 
agent in PD fluids. Filtration and large molecule transcapillary transport is not blood 
flow-dependent and an increase in capillary flow may therefore lead to rapid 
disappearance of the osmotic gradient and, consequently, termination of the 
ultrafiltration process. While no broad generalization regarding the relationship 
between vasoactive agents and permeability may be made, it should be noted that 
many vasodilators also act to increase microvascular permeability [10]. For example, 
bradykinin and histamine increase both blood flow and permeability [11,12]. 
In maintaining the ultrafiltration and solute clearance, preservation of the peritoneal 
tissue is of great importance. Despite a great amount of work having been performed 
to investigate the bioincompatible effects of the different components of the PD fluids 
on the peritoneal cells and tissue, the composition of the PD fluids has remained 
more or less unchanged over the years. 
Composition of peritoneal dialysis fluids 
The components of the PD fluids are generally an osmotic agent, electrolytes, and a 
buffer solution. As osmotic agent, glucose is used, mainly because it is cheap and 
easily metabolized. The drawbacks of using glucose are rapid absorption (and, 
consequently, short ultrafiltration time), the exposure of the patient's metabolism to a 
2 
large amount of carb ohydrate, and instability during heat sterilization and storage 
[2], which contributes to formation of toxic glucose degradations products (GDPs). 
The composition of electrolytes (Na+, Cl-, Ca2+, and Mg2+) is similar to that found in 
blood plasma. However, it has been suggested that low sodium concentrations in 
dialysate may be beneficial for patients with overhydration and may prevent 
cardiovascular problems [13]. 
The physiological buffer in the body is bicarbonate. However, the use of bicarbonate 
in PD fluids may cause precipitation of calcium carbonate during storage of 
carbonate buffer solutions. Currently, lactate is the most commonly used buffer in 
PD fluids. Lactate is present in human plasma; however, the levels of lactate ion in 
PD fluid are up to 80 times higher than those found in human plasma [14], Recent 
studies have shown that lactate-containing PD fluids induce pronounced 
morphological changes of the peritoneum, such as neoangiogenesis and mild 
damage to mesothelial cells [15]. Since pyruvate-based PD solutions have been 
shown to be more biocompatible than lactate-based ones, pyruvate has been 
suggested as a buffer of choice [16]. 
Structure and function of the peritoneum 
The peritoneal cavity contains a small amount of fl uid (about 0.5-1.0 dl), in which 
different types of leukocytes, principally monocytes/macrophages (90%), 
neutrophils (5%), and lymphocytes (5%), are suspended. The main phagocytes of the 
normal peritoneal cavity are not polymorphonuclear leukocytes, but 
monocytes/macrophages [17]. Plasma proteins are present at concentrations 
approximately equal to those normally found in plasma. The peritoneal cavity is 
lined with a monolayer of mesothel ial cells. These are formed in a cobblestone layer 
and are covered with surface microvilli. Besides a high synthetic activity, the main 
function of the mesothelium is lubrication of the peritoneal wall and protection of the 
submesothelial tissue from exposure to invading microorganisms and toxic products. 
The submesothelial tissue is separated from the mesothelium by a basal membrane. It 
contains collagen fibers in a matrix of ground substance. Embedded in the tissue are 
cells, blo od capillaries, and lymphatics. Normally, only a few cells are present, 
mostly fibroblasts, mast cells, lymphocytes, and macrophages. The microcirculation 
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of the peritoneal membrane provides the site for physiological interaction and 
exchange between the circulating blood and the cells and fluid of the peritoneal 
cavity [8], 
The inflammatory response of the peritoneum 
The resident defending cells of the peritoneum are located at four different sites: in 
the submesothelial connective tissue, in the submesothelial perivascular unit, 
suspended in the peritoneal fluid, and adherent to the peritoneal lining. 
Macrophages, mesothelial cells, lymphocytes, mast cells, and opsonins of the 
peritoneal cavity play an important role in the defense of the human host against 
bacterial pathogens. The principal opsonins in the fluid in the peritoneal cavity, as in 
plasma, are IgG, complement components, and fibronectin [2,17]. 
Following a bacterial infection of the peritoneal cavity, the initial reaction (i.e., within 
the first 2 hours) is activation of the plasma system (complement, kinin, and 
coagulation systems) and the intraperitoneal (i.p.) m acrophages. Activation of the 
complement system may lead to opsonization of the invading bacteria, thus 
preparing their recognition by phagocytes and Chemotaxis, resulting in neutrophil 
migration. Activation of m acrophages by the plasma systems and by opsonized or 
unopsonized microorganisms results in secretion of bo th prostaglandins (TXB,) and 
PGE2) and cytokines (IL-lß,IL-lcx, TNF-a, andIL-8). As a consequence, mesothelial 
cells start to synthesize prostaglandins and cytokines, in particular PGE2 and PGI2, 
together with IL-lß and IL-8. Of these, IL-8 is a powerful chemoattractant for 
polymorphonuclear cells [18-20], 
The dominating cell type recruited by the acute inflammatory response to a bacterial 
and fungal infection is the neutrophils from the venules of the peritoneal 
microcirculation. An increase in the neutrophil fraction of the PD effluent is 
commonly seen as an early diagnostic criterion for bacterial peritonitis [21], 
Inflammatory stimuli such as thrombin released by the coagulation system, 
complement products (e.g., C5a), and various cytokines (e.g., TNF-a and IL-8) 
activate the endothelium of the venules. The activation leads to expression of 
adhesion molecules, which mediate adhesion and activation of neutrophils and other 
leukocytes. The cells reversibly adhere to the endothelium and roll slowly along the 
vascular wall, predominantly in the small venules. Glycoprotein molecules called 
4 
selectins mediate this reversible adhesion, this being the first step in the recruitment 
of neutrophils. The selectin that is constitutively expressed on the surface of 
leukocytes, L-selectin, interacts with the endothelium selectins P-selectin and E-
selectin (see Fig. 1, top panel; P-selectin not shown). This interaction is highly 
coordinated and complex. P-selectin, which is carried inside endothelial cells in 
granules known as "Weibel-Palade bodies", appears on endothelial cell surfaces 
within a few minutes of exposure to LTB4, C5a, or histamine. The second selectin, E-
selectin, appears a few hours after exposure to lipopolysaccharide or TNF-®. The 
interaction of P- selectin and E-selectin with L-selectin allows neutrophils to adhere 
reversibly and to roll along the vessel wall. This adhesive interaction permits the 
stronger interaction of the second step in the leukocyte recruitment. 
The second step in neutrophil recruitment depends upon interactions between the 
neutrophil integrins known as LFA-1 (CDlla/CD18) and MAC-1 (CDllb/CD18) 
and molecules on endothelium, such as the immunoglobulin-related intercellular 
adhesion molecule 1 (ICAM-1), which is also induced by TNF-® (Fig. 1, bottom 
panel; MAC-1 not shown). Normally, LFA-1 and MAC-1 adhere only weakly, but IL-
8 or other chemoattractants trigger a conformational change in integrins on the 
rolling neutrophil, which greatly increases their adhesive capacity. Thereafter, L-
selectin is downregulated from the cell surface [8], The firmly adherent neutrophil 
may then migrate across the vessel wall towards the peritoneal cavity by a process 
that is dependent on LFA-1, MAC-1, and ICAM-1. The movement through the vessel 
wall is known as "diapedesis", the third step in neutrophil recruitment. The fourth, 
and final, step is the migration of t he neutrophil through the submesothelial tissue 
and to the peritoneal cavity under the influence of chemoattractant cytokines 
(chemokines) [22]. This directional migration is called "Chemotaxis". The most active 
chemotaxins are the complement split product C5a, bacterial chemotactic peptides (f-
MLP) and the CXC chemokines (a cytokine of the IL-8 f amily, cytokine-induced 
neutrophil chemoattractant 1 (CINC-1)) [23, 24], It is thought that C5a is involved in 
the initial recruitment of neutrophils and that IL-8 is responsible for more prolonged 
recruitment over a 6-48 hour span [25]. 
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Figure 1. Recruitment of neutrophils, steps 1-4. (Diagram from Immunobiology. The Immune System in 
Health and Disease, Janeway, 4th edition, 1999 [22]). 
Mast cells are actively involved in inflammatory and repair processes since they 
release a wide range of proinflammatory, vasoactive mediators, cytokines, and 
growth factors in response to activation by immune and non-immune liberators [26], 
The migration and the activation of neutrophils during an inflammatory response 
result from several events. Among these, an important role has been ascribed to the 
release of chemoattractants by resident cells, and it has been shown that during 
inflammation, macrophages, mast cells, or lymphocytes control neutrophil influx by 
release of cytokines, chemokines, or LTB4 [27, 28], The importance of mast cells in 
neutrophil recruitment into the peritoneal cavity was confirmed by Ramos et al. [29]. 
Neutrophil migration induced by IL-8 into the peritoneal cavity was not observed 
when the peritoneal resident mast cells were depleted, however; nor did Ramos et al. 
show this IL-8 dependent neutrophil migration to be dependent on LTB4, 
prostaglandins, or TNF-® [29]. 
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The complement system 
Another event resulting in neutrophil activation and migration is the activation of 
complement system. The complement system is made up of a large number of 
distinct plasma proteins, which, like the coagulation system, use a cascade of 
reactions to become activated. The complement system uses three different strategies 
for recognizing microorganisms and other foreign materials introduced into the 
body. The classic pathway of co mplement activation is triggered by antibodies bound 
to antigens on a microbial surface. In this pathway, the complement proteins work 
together with antibodies to enhance the clearance of antigen. The other two 
pathways provide for complement activation in the absence of antibody. They are the 
alternative pathway of complement activation, which is triggered directly by 
constituents of bacterial cell surfaces or foreign surfaces (e.g., biomaterials), and the 
lectin-rnediated pathway, which is activated by the binding of a mannose-binding 
protein present in blood plasma to mannose-containing proteoglycans on the 
surfaces of bacteria and yeast. All three pathways result in formation of a C3 
convertase enzyme (Fig. 2), which cleaves C3 into C3b and C3a fragments. The C3b 
fragment becomes covalently bound to the pathogen or foreign surfaces. C3b bound 
to the microbial surfaces can either bind to complement receptors on phagocytic cells, 
which facilitate phagocytosis of the pathogen, or activate the terminal components of 
complement, which attack the integrity of the pathogen's cell membrane. The smaller 
C3a fragment, together with similar fragments, C4a and C5a, induces inflammation 
by recruiting inflammatory cells into the area of complement activation. 
The complement activation product C5a may be a major chemoattractant for, and 
activator of, phagocytic cells, but it can also directly activate mast cells [22] and 
endothelial cells [30]. The latter induce upregulation of P-selectin, thus facilitating 
adhesion of neutrophils. C5a has been shown to be an important factor stimulating 
many processes of acute inflammation [31]. The significance of C5a in several 
inflammatory diseases is demonstrated by the fact that agents that block the action of 
C5a have also been observed to suppress inflammation in several animal models [30]. 
However, there has been little direct evidence demonstrating the in vivo requirement 
for C5a in experimental inflammatory models or clinical inflammatory states. 
One protein used in experimental models is cobra venom factor (CVF), the 
complement-activating protein in cobra venom. Cobra venom factor is closely related 
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to C3, binds mammalian factor B in plasma and, after cleavage of fact or B by factor 
D, produces C3 and C5 convertases that are very stable, with a serum half-life of 7 
hours at 37°C [32]. The CVF-Bb convertase consumes all plasma C3, In experimental 
animals, CVF can wipe out complement activity for between 24 and 72 hours, and 
with multiple dosing, decomplementation can be maintained for up to 1 week [33]. 
Cobra venom factor has been shown to be highly effective in many experimental 
models of complement-mediated pathologies and has provided a useful proof of 
concept for the notion that complement activation is of relevance in diverse 
pathologies. Studies using CVF in bacterial and viral infections, in tumor models, 
and in studies of the immune response have revealed the negative side of anti-
complement agent loss of an important player in immune surveillance. 
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Figure 2. Simplified overview of human complement system. The complement can be activated via 
three pathways: the classic, alternative, and lectin-mediated pathways. 
Complement factors C3a and C5a are known activators of mast cells and phagocytes. 
The main functions of the phagocytes upon reaching the inflammatory focus are 
phagocytosis, production of rea ctive oxygen species (respiratory burst), and reactive 
nitrogen intermediates (non-oxygen-dependent), needed to eliminate a bacterial or 
fungal infection. The respiratory burst is an important inflammatory response of t he 
phagocytes. Oxygen radicals are formed both extracellularly and intracellularly 
inside the phagosome, through a burst of o xygen reduction, which is caused by a 
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nicotinamide adenine dinucleotide phosphate (NADPH) oxidase complex that 
assembles at the cell membrane and the phagosomal membrane. The production of 
oxygen radicals is important for the extracellular and intracellular killing of 
microorganisms [34]. 
Phagocytosis is initiated by the binding of th e microorganisms to the surface of th e 
phagocytic cells, a process that requires some kind of recognition. The 
microorganism may have been primed with opsonins, IgG and the complement 
cleavage product C3b being the most important. The opsonins bind to specific 
receptors such as the polymorphonuclear leukocyte Fc (PMN-Fc), with CR1 
supporting the attachment. This stimulates the metabolic activities necessary for 
killing the microorganism [2], and initiates phagocytosis. 
Both free and phagocytosed organisms are removed by transit of p eritoneal fluid 
through the peritoneal lymphatics, principally across the diaphragm [17]. 
The coagulation system 
Just like complement activation, coagulation proceeds through a cascade of reactions, 
by which inactive factors become enzymatically active following surface contact, or 
through proteolytic cleavage by other enzymes. The newly activated enzymes in turn 
activate other, normally inactive precursor molecules. The system is conventionally 
divided into an intrinsic and an extrinsic pathway that converge on a common 
pathway, which terminates in thrombin generation (Fig. 3). Thrombin converts 
soluble plasma fibrinogen to fibrin monomers, which are stabilized by catalyzation of 
factor XHIa. Platelets become activated by generated thrombin and are trapped in the 
fibrin network [35]. 
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Figure 3. Overview of the coagulation system (Source: M.W.King, 1996). 
The coagulation cascade has recently attracted some attention and there are data 
demonstrating an increased turnover of fibrin in PD patients [36]. Coagulation factor 
Xa has proinflammatory properties [37, 38]. Thrombin, in addition to its essential role 
in the process of thrombus formation, plays a pivotal role in the inflammatory 
immune response and exerts receptor-mediated effects on a number of different cells 
[39], including mast cells [40], endothelial cells, mesothelial cells [41], monocytes, and 
neutrophils [26], The proinflammatory effects of thrombin on cells are probably 
mediated by membrane-bound protease-activated receptors (PARs) [26], The 
thrombin effects include leukocyte adhesion and Chemotaxis, cytokine production, 
and fibroblast proliferation. Thrombin may even induce release of vascular 
endothelial growth factor (VEGF) [42], thus forming a link between coagulation and 
angiogenesis. 
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The effect of insti llitig continuous ambulatory peritoneal dialysis fluid i nto 
the peritoneum 
Acute pro-inflammatory effect of peritoneal dialysis fluids 
A single i.p. injection of PD fluid causes an inflammatory reaction characterized by 
the recruitment of neutrophils to the peritoneal cavity [43]. The mechanisms behind 
this proinflammatory effect largely remain obscure and are a main focus of our 
studies. The effect may hypothetically be due to certain properties of t he PD fluid, 
such as hyperosmolarity or a low pH, exerting a proinflammatory action [2], possibly 
mediated through activation of c omplement, coagulation and mast cells. Mast cells 
are sensitive to changes in osmolarity [44]. High osmolarity also enhances the 
production of TNF-a by unstimulated peripheral blood mononuclear cells [45]. 
However, the mechanisms behind these effects are yet unkown. 
Dilution of cells and opsonins 
The obvious effect of i nstilling CAPD intraperitoneally (i.p.) is that both cells and 
proteins are diluted, initially to very low concentrations. Thereafter, the cell counts 
and protein concentrations rise [46], By the end of a clinical PD dwell, the cell 
concentration is only about 1-10% of normal and the concentration of plasma 
proteins is only 2-4% of plasma levels [17]. 
Toxic effects on cells 
Degradation of glucose (caramelization) during heat sterilization results in formation 
of cyt otoxic glucose degradation products (GDPs), such as different aldehydes [47], 
formic acid [17], and 3,4-dideoxyglucosone-3-ene (3,4-DGE) [48]. Glucose 
degradation products inhibit the in vivo respiratory burst response of both peritoneal 
macrophages [49] and neutrophils [50] and consequently possess anti-inflammatory 
properties. As well as the toxic effect of the dialysate on the peritoneal phagocytes, 
the constant removal of large numbers in the dialysate results in a younger 
population of cells showing fewer signs of maturation [51]. Mesothelial cell 
production of cytokines is also strongly inhibited [52], as is leukotriene production 
[53]. Consequently, the peritoneum in CAPD patients acts as an 
immunocompromised site. Peritoneal dialysis fluids developed more recently 
contain much lower levels of GDPs due to sterilization in multi-compartment bags. 
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In most of our experiments, in order to eliminate GDP effects, we used filter-
sterilized PD fluids also containing very low GDP levels. 
Chronic effects of peritoneal dialysis fluids 
Chronic inflammation is characterized by prolonged presence of macrophages, 
monocytes, and lymphocytes, with proliferation of blood vessels (angiogenesis) and 
connective tissue, and manifests as persistently high levels of inflammatory 
mediators [54]. Increased i.p. production of IL-6, IL-8, and IL-1 has been described in 
peritonitis-free CAPD patients. Even prostaglandin (PGE,) levels may be increased in 
the effluents after 1 year of CAPD, which could possibly be linked to mesothelial 
cells, since isolated macrophages from chronic CAPD patients do not show an 
enhanced capacity to produce prostaglandins [55], 
It i s known that long-term CAPD causes structural changes to the peritoneum, at 
different levels. Documented observations include mesothelial hyperplasia and loss 
of microvilli, interstitial fibrosis or expansion, thickening of the mesothelial basement 
membrane, and vascular changes. The structural changes are probably connected to 
changes in permeability of the peritoneal membrane and in the long run cause 
ultrafiltration failure, which necessitates transfer of the patient to another treatment 
modality. No links have, however, been shown between the alternations of the tissue 
and the clinical outcome [2]. 
Besides the biological effects of the PD fluids, recurrent peritonitis is the main cause 
of structural changes to the peritoneal membrane. Consequently, the peritoneal 
immune system plays an important role in prevention of infectious complications. 
Obviously acute infectious peritonitis implies the entry of patho genic organisms into, 
and their multiplication within, the peritoneal cavity. In some instances, poor 
technique, poor training, and poor hygiene are clearly at fault; but in the majority of 
patients with recurrent peritonitis, there are no records of more frequent prior-
technique failure than during periods without peritonitis. The recently developed PD 
fluids, with lower GDP content, are less toxic to cells of the peritoneal immune 
system. Despite this, there is no data showing that the new fluids reduce peritonitis 
frequency or outcome in clinical studies. Attention has therefore turned to host 
factors, which may determine poor resistance to the microorganisms involved. This 
in turn has led to studies of normal peritoneal immunology [17]. 
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Additives in peritoneal dialysis fluids 
Use of a dditives in the PD context is a new practice and generally aims to increase 
the dialysis fluid's biocompatibility. Heparin, a glycosaminoglycan, is the most 
frequently used drug in PD, and serves the purpose of preventing fibrin formation 
and catheter obstruction [56]. In a recent cross-over study, 3 months' treatment with 
low-molecular-weight heparin (LMWH) increased ultrafiltration and reduced 
glucose transportation in PD patients [57], 
Low-molecular-weight heparin is a direct inhibitor of factor Xa and has also 
demonstrated an ability to inhibit angiogenesis, induced by various agents, in the rat 
mesentery [58, 59]. Low-molecular-weight heparin has effects on the complement 
system [60] as well as on the coagulation system, in addition to possible direct effects 
on VEGF [59] and other growth factors [61]. In animal models, heparins and related 
compounds have demonstrated the ability to increase ultrafiltration, especially in the 
presence of i.p. inflammation. It has been assumed that anti-inflammatory actions are 
responsible for this effect [62, 63], 
Another glycosaminoglycan under investigation is hyaluronan (HA), a high-
molecular-weight (HMW) linear polysaccharide [64], which is naturally produced in 
the peritoneal cavity by peritoneal mesothelial cells, fibroblasts, and, to a lesser 
extent, macrophages. When added to the dialysis fluid, HA has been shown to exert 
anti-inflammatory and anti-fibrotic actions on the in vitro cultured human 
mesothelial cells (by inhibiting the synthesis of monocyte chemoattractant protein-1 
(MCP-1), s-ICAM, vascular endothelial growth factor (VEGF), and fibronectin) and 
accelerate their growth rate, which may be important for peritoneal healing during 
PD [65], However, the clinical effect of HA is under evaluation. 
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AIMS 
The aims of the present thesis were to: 
- examine potential interactions between complement factor C5a, the coagulation 
system, and a member of the IL-8 family, CINC-1, and evaluate the possible 
contribution of C5a to the acute inflammatory response to PD fluids 
- examine the possible role and involvement of mast cells in the acute peritoneal 
inflammatory response to PD fluids 
- investigate the effect of LMWH on peritoneal ultrafiltration, complement, and 
the coagulation system 
- study the effect of heat-sterilized glucose PD fluids in vivo on complement 
activation, CINC-1 levels, neutrophil recruitment, and respiratory burst response 
during experimental peritonitis. 
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MATERIALS AND METHODS 
Peritoneal dialysis fluids 
The laboratory made PD fluid, used in this thesis was composed of the following 
ingredients: glucose 140 mM, sodium chloride 92 mM, calcium chloride 1.35 mM, 
magnesium chloride 0.25 mM, and sodium lactate 40 mM. In paper IV, pH was 
adjusted to 5.4 and in papers 7-/77 p H was adjusted to 7.2 before sterilization. 
Sterilization was performed by autoclaving for 1 hour at 120°C (paper IV) , a method 
referred to here as "H-PD", or filtering (paper I-1V) in 0.2 ]Um cellulose acetate filters 
(Nalgene1 0.2 UM SFCA 150 ml Nalgene, NUNC International, New York, NY, 
USA), a method referred to as "F-PD". 
Experimental procedures 
1. in vivo 
Peritoneal dialysis flui d exposure models 
Initially, two different experimental models were used (papers I and III) t o evaluate 
the effect of PD on acute inflammatory response in peritoneum. The first model was 
based on a direct i.p. injection and the second, on a single infusion through an 
indwelling catheter implanted in the abdominal muscle 6-7 days prior to experiments 
(papers I and IV). By comparing the models, the dependence on known complement-
activating mechanisms such as trauma and the presence of a PD catheter could be 
evaluated. One of the major advantages of the catheter model is that it facilitates 
taking samples of the i.p. fluid at different time intervals. In addition, the catheter 
model is more similar to clinical PD than the injection model. 
Effects of heparin on utlrafi! t ration, complement, and coagulation 
The effect of LMWH in PD in rats was studied after addition of LMWH to the PD 
fluids. The animals were exposed to PD fluids during a 2-hour dwell using the 
catheter and the injection models. 
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A LMWH preparation with a molecular weight of 5,000 Dalton and a specific activity 
of 125 U/mg (Fragmin®; Pharmacia Sverige AB, Stockholm, Sweden) was added to 
20 ml PD fluid in some animals. Untreated and sham-injected animals were included 
as controls. In the catheter model, samples of i.p. fluid taken immediately after the 
PD fluid infusion served as controls and paired comparisons were made with 
samples taken after 2 hours. Experiments were ended by performing peritoneal 
lavage. Analyses of the retrieved fluid samples included drained volume, i.p. 
volume, cell numbers, glucose concentration, complement activation, thrombin 
production, and in vitro chemotactic activity. In some animals, complement and 
coagulation factors were measured from plasma samples obtained immediately 
before and after the PD dwell. Additional in vitro experiments were performed in 
order to study the direct blocking effect of LMWH on rat C5a /C5a-desArg. 
Evaluation of anti-inflammatory glucose degradation produc t effects in peritoneal dialysis in 
experimental peritonit is 
In order to investigate the impact of GDPs on leukocyte recruitment to the peritoneal 
cavity and the capacity of recruited neutrophils to mount a respiratory burst after in 
vivo exposure, two different models of experimental peritonitis were used. Both were 
based on i.p. fluid injections (20 ml) and dwell times of 2 or 4 hours. 
In the first model, peritonitis was induced by zymosan particles (4.4 mg zymosan A 
#Z-4250; Sigma Chem. Co., St. Louis, MO, USA). The zymosan particles were 
suspended in 20 ml of either Hanks buffered salt solution (HBSS) or heat-sterilized or 
filtered PD fluid, and injected i.p. Both unopsonized zymosan particles and particles 
opsonized for 30 minutes in rat plasma at 37°C were studied. Intraperitoneal 
complement activation was measured from the concentration of C3a-desArg, and i.p. 
release of CINC-1 was measured directly from the samples of peritoneal lavage fluid. 
Neutrophil recruitment was assessed from the cell counts in the peritoneal lavage 
fluid after a 4-hour dwell and from differential counts made on cytocentrifuge 
preparations. The respiratory burst of the neutrophils in response to opsonized 
zymosan was evaluated in vitro by chemiluminescence. The effects of PD fluid 
without zymosan were evaluated in separate experiments. 
In the second model, chemical peritonitis was induced by an i.p. injection of HBSS. 
The PD fluids (heat- or filter-sterilized) were injected i.p. after preexposure for 8 
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hours to HBSS [49, 50], After a 2-hour PD fluid dwell, peritoneal lavage was 
performed. Cells were characterized and counted. The respiratory burst of the 
neutrophils in response to opsonized zymosan was evaluated in vitro b y 
chemiluminescence. 
Effects of complement C5 in vivo blockade and the role ofCINC- l'in peritoneal dialysis 
Using the catheter model, rats were exposed to a single dose of 20 ml of filter-
sterilized PD fluid with or without addition of anti-rat C5 antibody 0.1 mg/ml 
(18A10.62; Alexion Pharmaceuticals, Cheshire, CT, USA). Samples of i.p. fluid, taken 
immediately after the PD fluid infusion, served as controls, and paired comparisons 
were made with samples taken after 2 and 4 hours. The dwell fluid was analyzed 
with regard to activation of the coagulation cascades, neutrophil recruitment, 
ultrafiltration volume, CINC-1, glucose, and histamine concentrations, and ex vivo 
i.p. chemotactic activity by blocking complement factor C5 and CINC-1. 
Functional study of peritoneal mast cells and complement 
The catheter model was used to expose the animals to a single dose of 20 ml filter-
sterilized fluid. Groups of animals were pretreated either with the mast cell stabilizer 
doxantrazole (Dox) (3-(lH-tetrazol-5-yl)-9H-thioxanten-9-one 10, 10-dioxide 
monohydrate) (catalogue #34,640-3; Sigma-Aldrich Co. Ltd., Gillingham, UK), 10 
mg/kg body weight (BW), administered intravenously (i.v.), 1 hour prior to PD, or 
decomplemented with CVF isolated from Naja melanoleucà (Venom Supplies Pty. 
Ltd., Tanunda, South Australia, Australia), 100 fig/kg BW, given i.v. 24 hours prior 
to exposure to filter-sterilized PD through an indwelling catheter, and compared 
with untreated controls. Samples of i.p. fluid, taken immediately after the PD fluid 
infusion, served as controls, and paired comparisons were made with samples taken 
after 2 and 4 hours. Analyses of the retrieved fluid samples included i.p. volume, cell 
numbers, and determination of histamine, rat mast cell protease 2 (RMCP-2), and 
CINC-1 levels. 
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2. Ex vivo/in vitro 
Evaluating intraperitoneal chemotactic activity 
In paper I, human polymorphonuclear granulocytes were used as probes to determine 
the chemotactic activity of the rat lavage fluid, due to their known cross-reactivity to 
rat C5a and C5a-desArg [66]. The cells were obtained from whole blood of healthy 
adult volunteers by density gradient separation, using Percoll® (Pharmacia Fine 
Chemicals, Uppsala, Sweden) according to the technique described by Braide and 
Bjursten [67], The cells were washed and suspended in HBSS, pH 7.20, before being 
used in the chemotactic assay. 
In paper I I, rat polymorphonuclear granulocytes were used as probes to determine 
the chemotactic activity of the i.p. fluid. The cells were obtained from whole blood of 
male Sprague-Dawley rats by density gradient separation using Percoll® (Pharmacia 
Fine Chemicals, Uppsala, Sweden) according to the technique described by 
Nannmark et al. [68], The cells were washed and suspended in phosphate-buffered 
saline (PBS), pH 7.20, for use in the chemotactic assay. 
Chemotaxis was measured in a twelve-well Chemotaxis chamber (Neuro Probe, Inc., 
Gaithersburg, MD, USA). The chamber was equipped with a single polycarbonate 
filter membrane (25 x 80 mm, pore size 3 jum, thickness 10 |im) and the exposed filter 
area for each well was 18 mm2. In paper I, the lower compartment of the chamber 
was filled with 160 fil PD fluid. Each fluid sample was distributed to three different 
wells for studying Chemotaxis, in the presence or absence of anti-C5 antibody, 0.1 
mg / ml (18A10.62; Alexion Pharmaceuticals, Cheshire, CT, USA), and chemokinesis. 
In paper 11, the lower compartment of the chamber was likewise filled with 160 pi PD 
fluid. Each fluid sample was then distributed to three different wells for studying 
Chemotaxis, in the presence or absence of a nti-rat CINC-1 antibody, 0.1 mg/ml (Lot 
#AIM014021; R&D Systems, UK), or anti-rat CINC-1 antibody in combination with 
anti-C5 antibody, 0.1 mg/ml. 
The upper compartment was filled with 120 jul HBSS (paper I) and PBS (paper II) in the 
Chemotaxis experiments and with PD fluid in the chemokinesis experiments. The 
chemotactic peptide f-Met-Leu-Phe 108 M in HBSS was used as positive control and 
HBSS alone was used as negative control in this assay. The chamber and fluids were 
warmed to 37°C and the wells were loaded with 30 pi of cell suspension (4 x 10fi 
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granulocytes/ml) to the upper surface of the filter. After incubation for 40 minutes at 
37°C in a humidified chamber, the filter was removed and the cells were scraped 
from the top side of t he filter. Remaining cells were then fixed in 4% formaldehyde 
för 10 minutes before labeling with propidium iodide (2 |Ug/ml; Molecular Probes, 
Eugene, OR, USA) for 7 minutes. The filter was mounted in Vectashield (Vector 
Laboratories, Inc., Burlingame, CA, USA) and evaluation was performed within 1 
day by fluorescence microscopy in order to quantify neutrophil migration. 
Chemotaxis was expressed as the number of cells that migrated through the 
membrane in relation to that in the positive control (i.e., f-Met-Leu-Phe) well. 
Blocking of ffioa-induc ed Chemotaxis in vitro 
The Chemotaxis assay employed to determine in vitro chemotactic activity of PD 
fluids was also used to study the blocking effects of LMWH and the monoclonal 
antibody (MAb) 18A10.62 on rat C5a/C5a-desArg in paper I. Zymosan-activated 
serum used as the source of C5a was prepared by incubating rat serum diluted 1:1 in 
HBSS for 1 hour with zymosan 20 mg/ml. After removing the zymosan by 
centrifugation, the serum was stored frozen until used. The blocking agents were 
added to both compartments and Chemotaxis was compared between blocked and 
unblocked chambers. The LMWH level was studied at concentrations of 6.25 and 
3.12 U/ml, the higher concentration corresponding to that used in PD fluid in vivo. 
The antibody 18A10.62 was studied at a concentration of 0.1 mg/ml. Chemotaxis was 
expressed as the number of m igrated cells in relation to the positive control (i.e., f-
Met-Leu-Phe) well. 
Animals 
Anesthesia 
The study protocol was approved by the Göteborg Ethics Committee. Male Sprague-
Dawley rats weighing between 250 g and 400 g were used in all experiments. General 
anesthesia was induced and maintained by inhalation of I sofluran Baxter® (Bax ter 
Medical AB, Kista, Sweden) in room air (papers I-III). 
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In paper I V, general anesthesia was induced by an intramuscular (i.m.) injection of 
pentobarbital sodium (1.5 mg/100 g BW) and diazepam (0.25 mg/100 g BW). During 
catheter implantation, the duration of anesthesia was approximately 20 minutes. 
During injections and infusions, the total duration of anesthesia was <10 minutes and 
the animals were awake during the rest of the dwell. At the end of the dwell, the 
animals were sacrificed under general anesthesia. 
The catheter model 
A 7 French silicone catheter (Renasil® SIL080; Braintree Scientific Inc., Braintree, MA, 
USA) was implanted under sterile conditions and general anesthesia. A midline 
incision was made through the abdominal skin and a hole was pierced through the 
linea alba with a 3 mm diameter needle, taking care not to cause any bleeding. After 
inserting 2.5 cm of the tip through the hole, the catheter was sutured to the 
superficial abdominal muscle fascia and the rest of the catheter was tunneled 
subcutaneously (s.c.) to the neck region and mobilized through the skin. After 
injecting 5 ml of saline, the catheter was closed with a stainless clip. The wounds 
were closed with wound clips. 
At 6-7 days after the catheter implantation, the animals were anesthetized and given 
a single 20 ml infusion of fi lter-sterilized PD fluid, with or without additive. Texas 
Red-labeled albumin was included as volume marker. A 1 ml fluid sample was 
drawn through the catheter and the animals were allowed to wake up. Two hours 
later (paper I) o r 2 and 4 hours later (papers II and III), the animals were anesthetized 
again and a new 1 ml fluid sample was drawn through the catheter. Before samples 
were taken, the animals were gently turned and their abdomens massaged in order 
to mix the i.p. fluid. The samples from the catheter at 0 and 2 (paper I) and 0, 2, and 4 
hours (paper III) were used for the analyses. In order to determine the rate of 
lymphatic fluid reabsorption from the i.p. space, a final fluid sample was taken after 
infusion of an additional 10 ml volume of PD fluid without labeled albumin. The 
animals were then sacrificed. 
Wash-out procedure 
In paper III, a group of animals were treated by an initial wash-out of the peritoneal 
cavity by immediately draining 12 - 15 ml of the infused PD fluid and replacing it 
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with the same volume of fresh fluid. The dwell and sampling was performed as with 
the other groups of animals. 
The injection model 
A single dose of 20 ml of heat- or filter-sterilized PD fluid, with or without additive, 
was injected into the abdominal cavity by a short needle. At the end of t he 2-hour 
dwell, peritoneal lavage was performed by injecting 20 ml of PBS supplemented with 
20 U / ml unfractionated heparin, gently shaking the animal and emptying the fluid 
through an abdominal midline incision. The animals were then sacrificed. The 
weight of the lavage fluid was determined and an EDTA-treated sample was 
retained for analysis of cytology and complement and coagulation factors. 
Analyses, measurements, and evaluations 
Cytological evaluation 
The samples were centrifuged at 400 g for 10 minutes in order to separate the blood 
cells, which were resuspended in a small volume of HBSS and counted. Cytospin 
preparations were made and evaluated cytologically (x 100 magnification) after 
staining in hem a tox-y li n-eos i n (H & E). At least 100 random cells were counted per 
slide and classified as basophils, eosinophils, neutrophils, or 
macrophages/monocytes. Cells that appeared to be damaged were excluded from 
the evaluation. 
Measurements of glucose, histamine, ami urea concentrations 
The cell-free samples (papers 1 and II )  were diluted 1:5 with lactate buffer at pH 5.5. 
After calibration for this dilution, glucose concentrations were measured with 
Ascensia Contour and Ascensia Microfill sticks (Bayer HealthCare, Bayer AB, 
Division Diagnostika, Göteborg, Sweden) based on pyrroloquinoline quinone (PQQ) 
glucose dehydrogenase and potassium ferricyanide. 
Histamine concentrations (paper I I)  were determined fluorometrically after reaction 
with o-phtalaldehyde according to the method described by Fredholm and 
Haegermark [69]. Urea concentrations (paper I) were determined from cell-free 
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samples, diluted 1:4 in distilled water, by applying a modification of the Sigma assay 
kit [70], 
Analyses of c omplement, coagulation, and cytokine-inducèd neutrophil chemoattractant 1 
and rat m ast cell protease 2 concentration 
In paper I, sodium EDTA, at a final concentration of 10 mM, was added to one portion 
of the peritoneal lavage fluid (injected animals) or present in the sampling device 
connected to the catheter or the blood vessel. Blood samples were spun to remove the 
blood cells. In paper I I, sodium EDTA, at a final concentration of 10 mM, was added 
to all samples (taken at 0, 2, and 4 hours). 
Complement activation (papers I and IV ) was determined from the concentration of 
C3a-desArg measured by enzyme-linked immunosorbent assay (ELISA) (rat C3a-
desArg ELISA #CL89160K; Cedarlane Laboratories Ltd., Hornby, Ontario, Canada), 
according to the manufacturers' instructions, in samples diluted 1:20. 
Coagulation was determined from measurements of the thrombin-antithrombin 
(TAT) complex (Enzygnost® TAT micro #OWMG 15; Dade Behring, Marburg GmbH, 
Marburg, Germany) (papers I a nd II). C3a-desArg and TAT levels were expressed as 
calculated total i.p. quantities (papers I and II) or, in the case of plasma samples, as 
concentrations (paper I). 
Cytokine-induced neutrophil chemoattractant 1 levels in papers II-IV were 
determined from the supernatants of i.p. fluid samples (Quantikine® Rat CINC-1 
Immunoassay, #RCN100; R&D Systems Europe, Ltd., UK). 
Rat mast cell protease 2 concentrations, in paper III, were determined from 
supernatants and plasma samples diluted 1:1 (RMCP-2 ELISA Kit, Cat.# MS-RM2; 
Moredun Scientific Limited, Edinburgh, Scotland, UK) according to the 
manufacturers' instructions. 
Measurements of respiratory burst 
Luminol (5-amino-2.3-dihydro-1.4-phatalzinedione, 5.5 mg/ml, in DMSO; Sigma 
Chem. Co., St. Louis, MO, USA)-amplified chemiluminescence was used in paper IV 
to measure the respiratory burst of the peritoneal leukocytes in vitro. The respiratory 
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burst was measured in response to zymosan opsonized in rat serum (30 minutes at 
37°C). 
A sample of the peritoneal cell suspension was diluted in order to obtain a cell count 
of 4.0 x 106 leukocytes/ml. An amount of 100 (il of the cell suspension was mixed 
with 100 jul luminol, diluted 1:20 in HBSS, and 100 f/1 of eit her opsonized zymosan 
(12.5 mg/ ml) or HBSS used as a control. The samples were immediately loaded into 
a luminometer (1251 luminometer; LKB Wallac Oy, Turku, Finland) controlled by a 
desktop computer. Measurements were performed every 30 seconds for 20 minutes 
and the mean values in mV were used in the evaluation. 
Determination of intraperitoneal fluid vol ume 
Fluorescently labeled albumin was used as a volume marker, according to a recently 
developed technique described by Bazargani et al. [71]. In brief, 100 ßg of Texas Red-
labeled bovine serum albumin (TR-BSA) (Molecular Probes, Eugene, OR, USA) and 1 
mg of unlabeled BSA were added to the PD fluid and a 1 ml sample was retrieved 
before i.p. injection. Intraperitoneal volumes were determined, between different 
cell-free samples, by spectrophotometric analysis (570 nm excitation and 615 nm 
emission). An intentional dilution of 10 ml PD fluid without TR-BSA, performed at 
the end of t he experiment, enabled measurement of t he true i.p. fluid volume at the 
time and was used to calculate the total fluid reabsorption during the 4-hour dwell. 
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Statistical analysis 
Throughout the analysis of d ata, non-parametric statistics were used. However, in 
the presentation, measured values are expressed as means + standard error of the 
m e a n  ( S E M ) .  T h e  W i l c o x o n - M a n n - W h i t n e y  t e s t  ( M a n n - W h i t n e y ' s  U - t e s t  i n  p a p e r  I V )  
and Wilcoxon's signed-ranks test were used to evaluate differences between 
independent and paired samples, respectively, and the Spearman rank-order 
correlation coefficient was used to evaluate correlations. Compensation for mass 
significances was performed using the sequentially rejective Bonferroni correction. 
The chosen level of significance was p<0.05. 
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RESULTS 
Effect of low-molecular-weight heparin on peritoneal dialysis in animals 
(paper I) 
Initially, we focused on the effect of LMWH on ultrafiltration, coagulation, and 
complement activation during a single PD dwell. In this paper, we evaluated the 
effects of LMWH supplementation on ultrafiltration, coagulation, and complement 
activation during a single PD dwell. The injection and the catheter models were 
studied and compared. 
The i.p. volumes obtained from measurements of Texas Red® albumin after PD fluid 
exposure increased in both models when LMWH was added to the PD fluid (Fig. 4 
[Fig. 1 in the paper]). The difference was significant in both the injection model and 
the catheter model. 
Injection model Catheter model 
LMWH 
Figure 4. Intraperitoneal (i.p.) volume increases, fo llowing dilution of Te xas Red-labeled albumin, 2 
hours after an i.p. injection (left) or a catheter infusion (right) of 20 ml of peritoneal dialysis (PD) fluid. 
Addition of 125 U low-molecular-weight heparin (LMWH) to the PD fluid significantly increased the 
drained volumes, indicating improved ultrafiltration. Brackets indicate statistically significant 
differences. 
Without supplementation with LMWH, an i.p. injection of 20 ml PD fluid induced 
neutrophil recruitment (Fig. 5; Table 1) and activation of the complement (Fig. 6) and 
coagulation (Fig. 7) cascades. 
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Figure 5. Peritoneal neutrophil recruitment, measured as intraperitoneal (i.p.) neutrophil numbers (in 
millions), 2 hours after an i.p. injection (left) or a catheter infusion (right) of 20 ml of peritoneal 
dialysis (PD) fluid. In the injected animals, the neutrophil numbers increased significantly compared 
with untreated (control) or punctured (sham) animals in the absence of low-molecular-weight heparin 
(LMWH). Addition of 125 U LMWH to the PD fluid significantly inhibited neutrophil recruitment. In 
the catheterized animals, the neutrophil numbers increased significantly over the 2-hour PD dwell in 
the presence or absence of LMWH. Brackets indicate statistically significant differences. 
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Figure 6. Peritoneal complement activation, measured as intraperitoneal (i.p.) C3a-desArg quantity, 2 
hours after an i.p. injection (left) or a catheter infusion (right) of 20 ml of peritoneal dialysis (PD) fluid. In 
the injected animals, the amount of C3a-desArg increased significantly compared with untreated 
(control) or punctured (sham) animals in the absence of low-molecular-weight heparin (LMWH). 
Addition of 125 U LMWH to the PD fluid significantly reduced the C3a-desArg level. In the catheterized 
animals, the C3a-desArg quantity increased significantly over the 2-hour PD dwell in the presence or 
absence of LMWH. Brackets indicate statistically significant differences. 
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Figure 7. Peritoneal thrombin formation, measured as intraperitoneal (i.p.) thrombin-antithrombin 
(TAT) quantity, 2 hours after an i.p. injection (left) or a catheter infusion (right) of 20 ml peritoneal 
dialysis (PD) fluid. In the injected animals, the amount of T AT increased significantly compared with 
untreated (control) or punctured (sham) animals in the presence or absence of low-molecular-weight 
heparin (LMWH). In the catheterized animals, the quantity of TAT increased significantly over the 2-
hour PD dwell in the absence of LMWH. Addition of 125 U LMWH to the PD fluid significantly 
inhibited the thrombin formation in both models. Brackets indicate statistically significant differences. 
Table 1 
Model Treatment Cell numbers, in millions 
Mononuclear 
cells 
Neutrophils Eosinophils Basophils 
Injection 
PD 7.66±1.69 10.03±3.14 2.22+0.51 1.37+0.36 
LMWH 12.90±0.88 0.10+0.05 1.98+0.32 1.94+0.48 
Sham 10.95± 1.29 1.61±0.84 1.94+0.48 1.26+0.29 
Control 11.57+1.25 0.00+0.00 2.07+0.46 0.62±0.20 
Catheter 
PD, Oh 4.71 ± 1.51 .1.67+0.87 3.32±1.08 0.02±0.02 
LMWH, 0 h 4.87±2.15 1.85±0.69 5.87±0.90 0.09±0.06 
PD, 2 h 11.33+5.03 9.27±2.35 7.08±2.13 0.00±0.00 
LMWH, 2 h 13.69±8.38 11.95±3.88 13.06+3.17 ().00±0.00 
Cell numbers, in millions, of different intraperitoneal (i.p.) leukocyte populations obtained from 
control animals, 2 hours after an i.p. injection and before (0 hours) and after (2 hours) a catheter 
infusion of 20 ml of peritoneal dialysis (PD) fluid. In untreated and sham-injected animals, the 
mononuclear cells dominated. In the catheterized animals, eosinophils and mononuclear cells 
dominated at 0 hours. Exposure to PD fluid increased the neutrophil fractions, but in the injected 
animals, this increase was inhibited by low-molecular-weight heparin (LMWH) supplementation. 
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Addition of LMWH significantly reduced cogulation (the amount of TAT present) 
after PD fluid exposure in both models (Fig. 7). In the injection model, the neutrophil 
numbers and complement activation (C3a-desArg quantity) after PD fluid exposure 
were also reduced by LMWH (Figs 5 and 6; Table 1). In the catheter model, there 
were no such effects. In vitro chemotactic activity was significantly increased after 
exposure to PD fluid in both models (Fig. 8). In vitro chemotactic activity of the 
lavage fluid was significantly inhibited by the addition of LMWH in the injected 
animals (Fig. 8). In the catheterized animals, there was a non-significant (p<0.076) 
tendency towards Chemotaxis inhibition by LMWH. 
Injection model Catheter model 
CSa active 
CSa blocked 
Control Sham PD LMWH 
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Figure 8. In vitro chemotactic activity (relative number of migrated neutrophils in a Chemotaxis 
chamber) of intraperitoneal (i.p.) fluid obtained 2 hours after an i.p. injection (left) or a catheter 
infusion (right) of 20 ml of peritoneal dialysis (PD) fluid. In the injected animals, the chemotactic 
activity significantly increased compared with untreated (control) or punctured (sham) animals. In the 
catheterized animals, the chemotactic activity increased significantly over the 2-hour dwell. Addition 
of 125 U low-molecular-weight heparin (LMWH) to the PD fluid significantly reduced the chemotactic 
activity in the injected animals. Ex vivo blocking of C5a with antibodies in the PD fluid samples 
significantly reduced the number of migrating neutrophils. Brackets indicate statistically significant 
differences. 
Blocking the PD fluid samples for C5a ex vivo led to a substantial and significant 
reduction in the number of chemotactic cells, indicating that a considerable part of 
the chemotactic activity was due to the presence of C 5a. After blocking of C5a, the 
remaining chemotactic activity was, however, still significantly elevated in the 
injection model. 
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The direct inhibitory effect of LMWH on C5a/ C5a-desArg was studied in vitro in the 
Chemotaxis assay using rat zymosan-activated serum as C5a source. At the 
concentration used in the in vivo experiments (6.25 U/ml), LMWH completely 
inhibited Chemotaxis of human neutrophils (Fig. 9). At the lower concentration, 3.12 
U/ml inhibition was weaker. The concentration of LMWH was significantly 
negatively correlated to Chemotaxis (correlation coefficient rho = -0.93). 
3.12 e. 
LMWH concentration (U/m!) 
Figure 9. In nitro chemotactic activity (relative number of migrated neutrophils in a Chemotaxis 
chamber) of zymosan-activated rat serum supplemented with LMWH at two concentrations. At the 
higher concentration of 6.25 U/ml, which corresponded to the concentration used in vivo, inhibition of 
Chemotaxis was total, indicating that LMWH blocks C5a and C5a-desArg, the chemotaxins present in 
zymosan-activated serum. Brackets indicate statistically significant differences. 
Role of complement factor C5a andCINC- 1 in peritoneal dialysis (paper II) 
In the second study (paper II), we took our investigation a step further, to evaluate the 
possible contribution of complement factor C5a and the potential interactions 
between C5a, the coagulation system, and a member of the IL-8 family, CINC-1. 
Ultrafiltration, glucose transport, neutrophil recruitment, and the levels of several 
mediators of inflammation and coagulation were studied in the catheter model. 
Monoclonal antibodies were used to block C5 in vivo. 
The levels of CINC-1 (Fig. 10), TAT (Fig. II), and histamine (Fig. 12) and the 
neutrophil numbers (Fig. 13) increased significantly during the PD dwell. The C5 
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blockade significantly reduced the initial levels of TAT and increased the 
ultrafiltration volumes at 2 hours (Fig. 14). Glucose concentrations were significantly 
positively correlated to ultrafiltration volumes at two hours and showed a tendency 
to increase under C5 blockade (Fig. 15). 
t=0 1=2 t=4 
Figure 10. Cytokine-induced neutrophil chemoattractant 1 (CINC-1) increased significantly 
during the dwell in both groups of animals (**p<0.01; *p<0.05). Compared with initial 
quantities, values measured at 2 and 4 hours were significantly higher. 
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Figure 11. Levels of the thrombin-antithrombin (TAT) complex increased over time in both groups, 
indicating that activation of the coagulation system was induced by the PD dwell (**p<0.01; *p<0.05). 
In the samples taken at 0 hours, TAT levels were significantly lower in the presence of C 5 blockade 
(p<0.01). 
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Figure 12. Intraperitoneal (i.p.) histamine levels increased in both groups after initiation of the dwell. 
Histamine quantities at 2 and 4 hours were significantly higher than initially with and without C5a 
blockade (**p<0.01 ; *p<0.05). 
\iHit "•;! 
Figure 13. Neutrophil numbers increased over time during the dwell in both groups of animals, 
although there was no significant difference between the groups at any time point. 
In order to detect the factors behind the chemotactic activity of the PD fluid samples, 
CINC-1 and C5 were blocked with MAbs ex vivo before measuring chemotactic 
activity. After blockade, chemotactic activity was below detectable limits at all three 
time points in both groups (data not shown), demonstrating that either C5a or CINC-
1 mediated all chemotactic activity in the samples. In order to quantify the C5a-
dependent chemotactic activity, CINC-1 was blocked ex vivo before measuring 
Chemotaxis. As expected, the remainder of chemotactic activity in animals treated 
with anti-C5 in vivo was virtually abolished at all time points (Fig. 16, right panel). In 
3 1  
the untreated group, ex vivo blockade of CINC-1 resulted in a progressive increase in 
C5a-dependent Chemotaxis over time (Fig. 16, left panel). 
AntiC 5a 
LU PD 
t=2h t=4h 
Figure 14. The ultrafiltration volumes at 2 hours, as measured by Texas Red® alb umin dilution, 
increased significantly (** = p < 0.01) in the presence of C5 blockade. After four hours the difference 
was insignificant (p=0.12). 
AntiC5a 
PD 
Figure 15. Glucose concentrations were not significantly affected by the C5 blockade, but there was a 
non-significant tendency towards an increase in total intraperitoneal (i.p.) glucose retention in the 
anti-C5-treated animals at 2 and 4 hours (p=0.08 and p=0.13, respectively). 
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Figure 16. (Left) In the animals not blocked for C5 (PD), the total chemotactic activity in vivo increased 
over time and was significantly reduced by the C5 blockade at all time points (**p<0.01; 
*p<0.05).(Right) When blocking the samples for cytokine-induced neutrophil chemoattractant 1 
(CINC-1) ex vivo, only the C5a-dependent chemotactic activity could be specifically measured. As 
expected, this activity was virtually absent at all time points in anti-C5-treated animals In the 
untreated group (PD), C5a-dependent Chemotaxis increased progressively over time and was 
significantly higher than in the C5-blocked animals at 2 and 4 hours (**p<0.01). 
The possible role and involvement of mast cells in the acute peritoneal 
inflammatory response to peritoneal dialysis fluids ( paper III) 
The third study (paper III) was performed to investigate the role of resident peritoneal 
mast cells on neutrophil recruitment, and examine whether mast cell activation in PD 
is secondary to complement activation. The catheter model was combined with the 
actions of functionally stabilizing the peritoneal mast cells with Dox, a stabilizer of 
mucosal and connective tissue mast cells, and consuming complement factor C3 by 
CVF. Untreated animals served as controls. 
Exposure to PD fluid invariably led to recruitment of neutrophils (Fig. 17) and 
release of C INC-1 (Fig. 18) into the peritoneal cavity. The CINC-1 levels increased 
approximately 20 times in the control group. Treatment with CVF reduced those 
effects insofar as the CINC-1 increase was only significant at 4 hours (p<0.05) and the 
neutrophil recruitment was only significant at 2 hours (p<0.05) following CVF 
treatment. Intraperitoneal histamine concentration changed little during the dwell, 
but a significant increase (p<0.05) was seen in all groups from 0 hours to 2 hours. At 
4 hours, the level remained elevated (Fig. 19). 
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Figure 17. Neutrophil counts in PD fluid samples at 0, 2, and 4 hours of dw ell time. Neutrophil counts 
were significantly higher at 2 hours (pcO.Ol) and 4 hours (p<0.01) compared with initial values in the 
control group (Con). Comparison of neutrophil levels at 2 and 4 hours revealed significant differences, 
at 4 hours, for doxantrazole (Dox) and cobra venom factor (CVF). Data are given in millions/ml and 
presented as means ± standard error of the mean (SEM). Each bar represents six to eight animals. 
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Figure 18. Cytokine-induced neutrophil chemoattractant 1 (CINC-1) concentrations in peritoneal 
dialysis (PD) fluid samples at 0, 2, and 4 hours of dwell time. The CINC-1 levels increased 
significantly, approximately 20 times in the control group (Con). Doxantrazole (Dox) did not 
significantly block the CINC-1 release. In cobra venom factor (CVF)-treated animals, the CINC-1 levels 
were significantly lower compared with controls at 2 and 4 hours (pcO.Ol). Values are given in pg/ml. 
Data are presented as means ± st andard error of the mean (SEM). Each bar represents six to eight 
animals. 
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Figure 19. Histamine concentrations in peritoneal dialysis (PD) fluid samples at 0, 2, and 4 hours of 
dwell time. Intraperitoneal (i.p.) h istamine concentrations changed little during the dwell, but there 
was a significant (p<0.05), approximately twofold, increase from time 0 to 2 hours in all groups. The 
levels remained elevated at 4 hours. Con = control; Dox = doxantrazole; CVF = cobra venom factor. 
Data, in ng/ml, are presented as means ± standard error of the mean (SEM) and each bar represents 
six to eight animals. 
During the dwell, RMCP-2, a marker of mucosal mast cells, increased slightly but 
significantly (p<0.05) in all groups (Fig. 20). 
Wash-out of the peritoneal cavity in the beginning of the dwell did neither reduce 
neutrophil numbers nor CINC-1 levels significantly at 2 or 4 hours. 
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Figure 20. Rat mast cell p rotease 2 (RMCP-2) concentrations in peritoneal dialysis (PD) fluid samples 
at 0, 2, and 4 hours of dwell time. Concentrations increased slightly but significantly (p<0.05) in all 
groups during the dwell. Cobra venom factor (CVF) did not have a significant effect on the RMCP-2 
levels. Doxantrazole (Dox) significantly (p<0.05) increased the RMCP-2 concentration at 2 hours. Con 
= control. Values are given in ng/ml. Data are presented as means ± standard error of th e mean (SEM) 
and each bar represents between six and eight animals. 
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CVF significantly increased the net ultrafiltration and the gross ultrafiltration (Fig. 
21). Fluid reabsorption rates did not differ between the groups and were 30.7+5.6 
111/min, 24.0+1.1 fil/min and 31.6+5.2 j/l/min for controls, doxantrazole and CVF 
treated animals respectively. 
NetUF 2h NetUF 4h UF 2h UF 4h 
Figure 21. Ultrafiltration volumes excluding (NetUF) and including (UF) lymphatic fluid reabsorption 
at 0, 2 and 4 hours of d well time. Decomplementation with cobra venom factor significantly increased 
ultrafiltration at 2 hours. Con = control; Dox = doxantrazole. Data are means ± SEM in ml and each bar 
represents 6-8 animals. 
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Effect of heat-sterilized peritoneal dialysis fluids on complement activation, 
CINC-1 release, and neutrophil recruitment (paper IV) 
The aim of th e last study (paper IV) was to compare the acute in vivo effects of GDPs 
on neutrophil recruitment, CINC-1 production, and respiratory burst response in 
relation to different mechanisms of inflammatory activation in the injection model. 
Experimental peritonitis was induced by zymosan, a known activator of the 
complement system, allowing a correlation of complement activation, CINC-1 
release, and neutrophil recruitment. 
Opsonized zymosan caused an inhibition of ul trafiltration, reducing the drained i.p. 
fluid volume to the level of th e isotonic HBSS (Fig. 22). Addition of zymosan to the 
PD fluid also led to complement activation (Fig. 23), release of CINC-1 (Fig. 24), and 
recruitment of neutrophils (Fig. 25) to the peritoneal cavity. Heat-sterilized PD fluid 
significantly inhibited CINC-1 release and the recruitment of neutrophils in this case. 
When unopsonized zymosan was used, however, neither the neutrophil recruitment 
nor the CINC-1 release was affected by the type of PD fluid used. In either case, 
complement activation was unaffected by the choice of PD fluid. Neutrophils 
recruited after a single injection of HBSS and exposed i.p. to heat-sterilized PD fluid 
showed a significantly impaired respiratory burst response (Fig. 26). 
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Figure 22. The drained volumes of peritoneal effluents from rats after intraperitoneal (i.p.) exposure to 
either Hanks buffered salt solution (HBSS) or filter-sterilized (F-PD) or heat-sterilized peritoneal 
dialysis (H-PD) fluid, with or without addition of zymosan (opsonized or unopsonized). Values, in ml, 
are presented as means ± standard error of the mean (SEM) and each bar represents five to seven 
animals. Addition of opsonized zymosan significantly reduced the drained volumes of PD fluids 
down to the level obtained with HBSS. Asterisks indicate statistically significant differences (p<0.05) 
between opsonized and unopsonized zymosan. 
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Figure 23. The measured complement activation in peritoneal effluents from rats after intraperitoneal 
(i.p.) exposure to either Hanks buffered salt solution (HBSS) o r filter-sterilized (F-PD) or heat-
sterilized peritoneal dialysis (H-PD) fluid, with or without addition of zymosan (opsonized or 
unopsonized). Values are given in jug. Data are presented as means ± s tandard error of the mean 
(SEM) and each bar represents between five and eight animals. Addition of z ymosan (opsonized or 
unopsonized) significantly increased the measured quantities of C3a-desArg. There were no 
significant differences between treatment with F-PD and treatment with H-PD. 
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Figure 24. The measured cytokine-induced neutrophil chemoattractant 1 (CINC-1) release in 
peritoneal effluents from rats after intraperitoneal (i.p.) exposure to opsonized or unopsonized 
zymosan in either filter-sterilized (F-PD) or heat-sterilized peritoneal dialysis (H-PD) fluid. The H-PD 
fluid significantly reduced the CINC-1 release induced by opsonized zymosan. The response to 
unopsonized zymosan did not differ significantly between the two types of PD fluids. 
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Figure 25. The neutrophil counts in peritoneal effluents from rats after intraperitoneal (i.p.) exposure 
to e ither Hanks buffered salt solution (HBSS) or filter-sterilized (F-PD) or heat-sterilized peritoneal 
dialysis (H-PD) fluid mixed with either opsonized or unopsonized zymosan. Figures are given in 
millions. Data are presented as means ± standard error of the mean (SEM) and each bar represents five 
to eight animals. The asterisks indicate a statistically significant difference (p<0.05) between F-PD and 
H-PD fluids. Data on the same fluids without addition of zy mosan (No zymosan) are included from a 
previous study [49], 
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Figure 26. The chemiluminescence in response in vitro to neutrophils exposed in vivo to ei ther filter-
sterilized peritoneal dialysis (PD) fluid (F-PD) or heat-sterilized PD fluid (H-PD), 8 hours after an 
intraperitoneal (i.p.) challenge with Hanks buffered salt solution (HBSS). Data are presented as means 
± standard error of the mean (SEM) and each bar represents six to eight animals. Values are given in 
mV. Asterisks indicate statistically significant differences (p<0.05). Data from a previous study on 
neutrophils from PD effluents without preexposure to HBSS (PD fluid at 4 hours) are included [49], 
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DISCUSSION 
Inflammatory response in experimental peritoneal dialysis 
This work was initiated to investigate the regulatory mechanisms behind the acute 
inflammatory response, in the peritoneal cavity, to PD. In both models (catheter and 
injection), exposure to PD fluid by i.p. injection or by a resident catheter led to rapid 
recruitment of neutrophils and increases in C3a-desArg, TAT and CINC-1 levels, 
detectable 2 hours later. Those changes were sustained or amplified at 4 hours. 
The i.p. baseline quantities of C3a-desArg, TAT and CINC-1 corresponded to those 
present in 2-3 ml of plasma (paper 1), indicating that before the PD dwell, there was a 
steady state between plasma and the i.p. fluid volume (2-3 ml). The rise in C3a-
desArg, TAT and CINC-1, seen during the PD dwell, was substantial and by far 
exceeded the contribution expected from exchange between plasma and the i.p. 
space. According to preliminary measurements on 125I-labeled albumin, the clearance 
from plasma to the peritoneum of these proteins should amount to <1 ml during a 2-
hour dwell in the present models. Consequently, at least 80% of the observed 
increases in C3a-desArg and TAT and an even larger fraction of the CINC-1 increase 
were due to i.p. formation of these factors. 
The effluent samples showed a significant chemotactic activity. Blocking of PD fluid 
ex vivo indicated that the recruitment of n eutrophils was mediated by either C5a or 
CINC-1. In order to quantify the C5a-dependent chemotactic activity, CINC-1 was 
blocked ex vivo before measuring Chemotaxis. As expected, the remainder of 
chemotactic activity in animals treated in vivo with anti-C5 was virtually abolished at 
all time points. In the untreated group, ex vivo blockade of CINC-1 resulted in a 
progressive increase in C5a-dependent Chemotaxis over time. This indicates that the 
neutrophil Chemotaxis in the peritoneum is induced by complement activation and, 
probably, first C5a and, later, CINC-1 release from resident mast cells, macrophages, 
or mesothelial cells. The observed parallel release of CINC-1 and histamine may have 
been the result of mast cell degranulation. However, the histamine levels were low 
and it cannot be excluded that the increase over time could have been caused by 
diffusion from the vascular bed. 
The present data suggest that there is a direct effect of the PD fluid on the peritoneal 
tissues or cells. Possible mechanisms include the dilution of the intraperitoneal fluid, 
changing the protein and cytokine levels, and the traumatic effects of distension and 
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osmosis on the peritoneal wall. The mechanisms behind the intraperitoneal 
activation of complement and coagulation are unknown. According to several 
clinical studies [72, 73], complement activation and coagulation [36] also take place 
continuously in CAPD patients. It has been speculated that the peritoneal 
inflammatory reaction in CAPD patients including complement and coagulation 
system activation, may be induced by endotoxins that diffuse from the 
gastrointestinal tract. Transmural migration of intestinal flora has been suggested as 
one of the patomechanisims underlying the peritonitis that develops in patients 
treated with PD [55], One other possible mechanism behind the inflammatory 
response in the peritoneum could be the effect of a neurogenic inflammation. It is 
known that injury or chemical stimulation of the sensory nerve endings leads to the 
release of neuropeptides. The released neuropeptides then cause vasodilation and 
increased vascular permeability, probably by binding to the NK] receptors on the 
vascular endothelium, resulting in a condition known as "neurogenic inflammation" 
at and around the site of stimulation [74, 75]. Among the various neuropeptides, 
substance P is believed to be the major mediator of neurogenic inflammation. In 
addition to the direct effect of substance P on the microvasculature, degranulation of 
mast cells has also been demonstrated to contribute to the symptoms of neurogenic 
inflammation [76]. Morphological studies have provided visual evidence which 
confirms the close anatomical association between mast cells and nerve fibers, 
especially those containing substance P [77, 78], Mast cell degranulation has also 
been documented in various in vivo models of n eurogenic inflammation of t he skin 
and gut [79]. We still don't know the mechanisms behind the activation of 
complement and coagulation cascades, but the complement activation seems to get 
engaged earlier in the course of events. 
Intraperitoneal injections and indwelling catheters represent the two main PD 
techniques used in animals. Available data do not indicate that one model induces 
less inflammation than the other and there is no consensus on which model is more 
suitable [80]. According to the only published comparative study [80], dialysate cell 
counts, submesothelial fibrosis, and peritoneal transport properties were identical for 
injections and catheters after 1 month of daily exposure to hypertonic PD solution. 
In the present study, the differences between the two models was evident from the 
beginning of the experiments, with the already elevated neutrophil and TAT levels in 
the catheter model. There was also a difference in D/D„ glucose between the two 
models, indicating a higher rate of glucose diffusion from the peritoneal cavity of the 
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catheter model. However, at 2 hours, i.p. volumes did not differ significantly 
between the models. Unpublished data on the two models show that between 2 and 
4 hours of dwell, i.p. volumes increase significantly in the injection model, while 
there is a tendency towards a decrease in the catheter model. Consequently, in the 
catheter model, the net reabsorption of fluid starts earlier. This is consistent with the 
lower glucose concentration found in the present study at 2 hours and indicates a 
larger available vascular surface area in the catheter model. Consequently, there is 
evidence that the two models differ also in terms of transport parameters. In the case 
of a single PD fluid exposure, the catheter model may be more relevant to clinical PD 
than the injection model, although the effects of the catheter per se in humans have 
not been clearly defined. 
Effects ofC5a blockade in peritoneal dialysis 
In paper 11, C5 blockade increased the ultrafiltration and reduced the early activation 
of the coagulation system. The tendency towards an improved retention of glucose 
during C5 blockade, though not significant, suggests that one mechanism behind the 
improved ultrafiltration is a reduction in glucose transport. This suggestion is 
supported by the finding of a significant positive correlation between glucose 
concentration and ultrafiltration, suggesting a connection between the increase in 
ultrafiltration caused by the C5 blockade and a reduction in the glucose transport 
from the peritoneal cavity. This may imply that C5a blockade inhibits inflammatory 
microvascular dilation and thereby reduces capillary flow velocities. C5a, in fact, has 
a vasodilatory effect on rat visceral arterioles mediated by nitric oxide [81] and nitric 
oxide blockade has been demonstrated to improve ultrafiltration [82]. Since glucose 
diffusion is much more flow-dependent than ultrafiltration, a reduction in capillary 
flow would decrease the out-diffusion of glucose [9], thus increasing the durability of 
the osmotic gradient and, secondarily, the cumulative ultrafiltration volume. An 
increase in glucose transport is a common mechanism behind ultrafiltration failure in 
PD patients, and blockade of C5a may therefore be a basis for increasing the 
efficiency of PD. However, there are many problems associated with the use of 
blocking antibodies raised against C5a in treating human patients. Immunogenicity 
is a common problem and proteins are expensive to manufacture, very susceptible to 
degradation by proteases in serum or the gastrointestinal tract, and generally display 
poor pharmacokinetic properties [31]. There are no specific low molecular weight 
complement-blocking drugs available. 
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Levels of t he TAT-complex increased over time in both C5-blocked and unblocked 
animals, indicating that activation of t he coagulation system was induced by the PD 
dwell. C5 blockade significantly reduced the initial levels of TAT. The demonstrated 
increase in ultrafiltration was paralleled by a significant reduction in levels of TAT in 
the samples taken immediately after initiation of the dwell. This indicates that C5a 
may be involved in mechanisms that initiate coagulation. Generation of the 
membrane attack complex during complement activation is known to induce pro-
coagulant activity in platelets and endothelial cells, leading to coagulation [83], and 
C5 blockade inhibits formation of C5b, which is necessary for the assemblage of the 
membrane attack complex. At later time points during the dwell, there were no 
significant effects of C5a blockade, suggesting either that additional, C5a-
independent, mechanisms of coagulation were at work or that the coagulation 
process was completed i.p. and was limited by the i.p. supply of coagulation factors. 
The heparin effect in peritoneal dialysis 
In paper I, we ev aluated the effect of LMWH on PD, complement, and coagulation 
cascades and compared the two main techniques for i.p. fluid administration in 
animal studies, in the injection model, and in the catheter model. 
Low-molecular-weight heparin showed the ability to block activation of the 
coagulation system and to reduce the i.p. chemotactic activity related to C5a, at the 
same time as increasing the ultrafiltration volumes. The two experimental models 
differed with regard to LMWH effects on neutrophil recruitment, the formation of 
C3a, and transport parameters. Complement activation and neutrophil recruitment 
were inhibited by LMWH only in the injection model, despite the fact that the 
reaction to PD fluid exposure was similar in both models. Addition of LMWH to the 
PD fluid, however improves ultrafiltration, inhibits formation of thrombin, and 
potentially blocks C5a activity in both models. 
According to established theories the alternative pathway, most probably involved in 
the present experiments, is activated by surfaces lacking the complement inactivators 
present in normal cell membranes. The PD catheter is the obvious provider of such a 
surface. This would in part explain the complement activation in the catheter model. 
But, complement activation also occurred in the injection model, suggesting other, 
yet unknown, mechanisms. 
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Since C3a-desArg was not significantly affected in the catheter model, LMWH 
probably interacted directly with C5a, or else, C5a-desArg formed downstream of 
the C3 activation. This assumption was supported by the in vitro blocking effect of 
LMWH on C5a. Direct inhibition of C5a by different heparins has been observed in 
Chemotaxis assays in vitro [60]. The magnitude of the LMWH-mediated increase in 
paper I was similar to that induced by blocking C5 in paper 11. Consequently, it 
appears that C5a blockade may be the dominant mechanism behind the acute effect 
of LMWH on ultrafiltration. There are, however, several additional properties of 
heparin that may be involved, such as its ability to inhibit coagulation or its binding 
of angiogenic growth factors [59, 61]. 
Mechanisms behind the release ofCINC-1 during peritoneal dialysis 
The third study (paper III) was initiated to examine the possible role and involvement 
of m ast cells in the acute peritoneal inflammatory response to PD fluids. The results 
demonstrate that complement activation plays a pivotal role in the early response to 
PD fluid exposure. The resulting intraperitoneal release of CINC-1 and the 
recruitment of neutrophils depend on the complement activation, since in our 
experiments, decomplementation with CVF virtually eliminated those responses. 
Complement activation leads to the formation of several potent mediators of 
inflammation, C3a and C5a being the most important. In paper II, the CINC-1 release 
was not affected by C5a blockade. Therefore, it is most probably mediated by C3a, 
which is formed in larger quantities than C5a during complement activation. C3a is a 
potent anaphylatoxin with the ability to activate a number of cellular processes, 
sharing with C5a the ability to activate mast cells. 
One hypothesis behind the present study was that the CINC-1 release induced by PD 
fluid is executed by mast cells, stimulated by C3a. Doxantrazole is, according to the 
literature, an efficient blocker of both mucosal and connective tissue mast cells [84, 
85], although its specificity for mast cells has not been documented. There are several 
ways in which the mucosal mast cells differ from the connective tissue mast cells. 
Most importantly, their granulae contain different proportions of the various 
mediators. Histamine quantities are much lower and the proteoglycans differ 
structurally from those of connective tissue mast cells [86]. While histamine is a good 
marker of connective tissue mast cell secretion, RMCP-2 is specific to mucosal mast 
cells. 
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In our study, Doxantrazole reduced the neutrophil recruitment and showed a 
tendency towards blocking the CINC-1 release without significantly lowering the 
histamine or RMCP-2 levels. The generally low histamine and RMCP-2 levels 
following PD fluid infusion indicate that neither the connective tissue mast cells, nor 
the mucosal mast cells were activated by the PD fluid exposure. Unlike findings in 
allergic reactions, mast cells are rarely seen to degranulate during autoimmune or 
inflammatory processes. Instead, they appear to undergo ultrastructural alterations 
of their electron-dense granular core, indicative of secretion, but without overt 
degranulation, a process that has been termed "activation" or "intragranular 
activation". Such subtle activation may be associated with the ability of mast cells to 
selectively release some mediators [87]. However, this finding is inconclusive and 
needs to be studied further. The slight increase in histamine concentration seen 
during the dwell in our study was probably due to leakage from the circulation since 
histamine is a relatively small molecule that clears rapidly over the peritoneal 
membrane. Plasma concentrations were considerably higher than the i.p. 
concentrations, making up a positive concentration gradient for this clearance. 
Similar conditions were in place for RMCP-2 clearance. The normal concentrations of 
RMCP-2 in rat plasma are in the range of 50 ng/ml [88], which is 25-50 times higher 
than those measured i.p. in paper III. 
Consequently, there was no robust evidence for mast cell activation. This implies 
that, instead, Dox blocked CINC-1 release from cells other than mast cells. However, 
mast cell blockers are generally not well characterized with regard to mechanisms of 
action and the documentation on Dox is no exception to this rule. The other main 
candidates among peritoneal cells for CINC-1 release are macrophages [89] and 
mesothelial cells [29], although little information is available in the literature on this 
subject. These cells are capable of inducing neutrophil migration and contributing to 
the high CINC-1 levels in our model; however, the mechanisms connecting them to 
the PD fluid response are unknown. Data from intraperitoneal wash-outs in the 
beginning of d wells neither showed significant effects on CINC-1 levels, nor on 
neutrophil numbers after 4 hours dwell although the wash-out reduced the 
macrophage population by at least 75%. This turns our attention towards the resident 
cells. The lacking evidence for mast cell degranulation implies that the importance of 
mesothelial cells should be evaluated. 
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The effect of glucose degradation products on CINC-1 release and neutrophil 
function 
The results of the last study (paper IV) indicate that GDPs formed during heat 
sterilization of PD fluids have inhibitory effects on important inflammatory 
mechanisms of experimental peritonitis in the rat. The recruitment of neutrophils to 
the peritoneal cavity after inducing experimental peritonitis with opsonized zymosan 
was significantly diminished by heat-sterilized PD fluid compared with filter-
sterilized PD fluid. This effect can possibly be explained by a parallel inhibition of 
the release of the chemokine CINC-1. When inducing experimental peritonitis with 
unopsonized zymosan, on the other hand, the GDPs influenced neither the 
recruitment of neutrophils, nor the levels of CINC-1 present i.p. Both types of 
zymosan induced a similar degree of i.p. complement activation, measured as an 
increase in the concentration of C3a-desArg, and the level of this complement 
activation was not influenced by the GDP concentration of the PD fluid. 
The reason for the increased sensitivity of CINC-1 release to GDPs remains obscure, 
but the finding is in line with results of a number of earlier studies on GDP toxicity. 
Exposure of human mesothelial cells to heat-sterilized PD fluid significantly 
impaired cell viability and the capacity for generating monocyte chemoattractant 
protein-1 (MCP-1) and production of IL-6 [90, 91] compared with filter-sterilized PD 
fluid [92]. Glucose degradation products hypothetically exert a wide range of 
inhibitory effects on cells by carbonyl-induced cross-linking of molecules such as 
surface proteins, intracellular proteins, and nucleic acids. For example, 
formaldehyde, a GDP species and a well-known fixative, easily penetrates the cell 
membrane and immediately cross-links several intracellular components. The 
complement system, though based on a series of catalytically active proteins, was not 
significantly affected by GDPs in paper IV. 
It is obvious that the two types of zymosan particles differ concerning their 
interaction with the immune system. The fact that opsonized zymosan reduced the 
ultrafiltration capacity of the PD fluid compared with unopsonized zymosan, 
indicates a difference also in the interaction with microvascular perfusion and /or 
permeability. 
Consequently, the results of the last study (paper IV) indicate that GDPs affect 
mechanisms of neutrophil recruitment that are independent of i.p. complement 
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activation, but probably involve chemokine release. The neutrophil respiratory burst 
response is significantly inhibited by GDPs if the neutrophils are present i.p. when 
the PD fluid is injected, demonstrating the importance of the rapid detoxification of 
GDP-containing PD fluid in vivo. Our results also suggest that some parts of the 
immune response, including the complement system, are not affected by GDPs. It 
also appears as if some routes of chemokine activation, such as that utilized by 
unopsonized zymosan, may be fairly insensitive to the GDP effects although other 
pathways, such as the one utilized by opsonized zymosan, may be significantly 
inhibited by GDPs. Hypothetical^, GDP effects on the immune response may favor 
certain pathogens, including those that do not activate complement. There is a range 
of microorganisms that inhibit complement activation and / or opsonization but 
neither of those is among the common pathogens of PD-associated peritonitis. 
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CONCLUSIONS 
The main aim of the present thesis was to elucidate the regulatory mechanisms 
behind the acute inflammatory response associated with PD fluid instillation in the 
presence or absence of experimental peritonitis. Clinical studies have demonstrated 
that i.p. complement and coagulation systems are activated in PD patients and that 
PD maintains a state of i.p. inflammation. Some PD fluids also have anti­
inflammatory properties, possibly interfering with the peritoneal immune response. 
Data from this thesis show that _ 
- complement activation is a very early step in the acute reaction to PD. It 
reduces ultrafiltration through the action of C5a and it p robably mediates 
the downstream events that lead to recruitment of inf lammatory cells to the 
peritoneal cavity. The cells involved in the release of C INC-1 later in this 
sequence are possibly mesothelial cells. However, the importance of the 
resident macrophages cannot completely be ruled out and remains to be 
investigated further. 
- blockade of C5 leads to an increase in ultrafiltration, probably by a 
mechanism that involves a reduction in glucose transport. This effect may 
form the basis for increasing PD efficiency. 
- supplementation of LMWH to the PD fluid improves ultrafiltration, inhibits 
formation of thrombin, and blocks C5a activity. 
the neutrophil respiratory burst response is inhibited by GDPs present in 
heat sterilized PD fluids if the neutrophils are present intraperitoneally 
when the PD fluid is injected. 
- GDPs in PD fluids also inhibit the recruitment of neutrophils to the 
peritoneal cavity by a mechanism that is not dependent on complement 
activation, but that probably depends on cytokine CINC-1 release. 
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